Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

364 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype.
Kresbach C, Dorostkar MM, Suwala AK, Wefers AK, Schweizer L, Engertsberger L, Bison B, Mynarek M, Kloth-Stachnau K, Spohn M, von Deimling A, Benesch M, Hagel C, Mautner VF, Rutkowski S, Schüller U. Kresbach C, et al. Among authors: rutkowski s. Acta Neuropathol. 2021 Jun;141(6):971-974. doi: 10.1007/s00401-021-02304-4. Epub 2021 Apr 12. Acta Neuropathol. 2021. PMID: 33844070 Free PMC article. No abstract available.
Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study.
Benesch M, Siegler N, Hoff Kv, Lassay L, Kropshofer G, Müller H, Sommer C, Rutkowski S, Fleischhack G, Urban C. Benesch M, et al. Among authors: rutkowski s. Anticancer Drugs. 2009 Oct;20(9):794-9. doi: 10.1097/CAD.0b013e32832f4abe. Anticancer Drugs. 2009. PMID: 19617818 Clinical Trial.
TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.
Pfaff E, Remke M, Sturm D, Benner A, Witt H, Milde T, von Bueren AO, Wittmann A, Schöttler A, Jorch N, Graf N, Kulozik AE, Witt O, Scheurlen W, von Deimling A, Rutkowski S, Taylor MD, Tabori U, Lichter P, Korshunov A, Pfister SM. Pfaff E, et al. Among authors: rutkowski s. J Clin Oncol. 2010 Dec 10;28(35):5188-96. doi: 10.1200/JCO.2010.31.1670. Epub 2010 Nov 8. J Clin Oncol. 2010. PMID: 21060032
Primary central nervous system primitive neuroectodermal tumors (CNS-PNETs) of the spinal cord in children: four cases from the German HIT database with a critical review of the literature.
Benesch M, Sperl D, von Bueren AO, Schmid I, von Hoff K, Warmuth-Metz M, Ferrari R, Lassay L, Kortmann RD, Pietsch T, Rutkowski S. Benesch M, et al. Among authors: rutkowski s. J Neurooncol. 2011 Aug;104(1):279-86. doi: 10.1007/s11060-010-0485-1. Epub 2010 Dec 22. J Neurooncol. 2011. PMID: 21181235 Review.
Ectopic craniopharyngioma.
Kordes U, Flitsch J, Hagel C, Goebell E, Schwarz R, Herberhold T, von Bueren AO, Rutkowski S, Müller HL. Kordes U, et al. Among authors: rutkowski s. Klin Padiatr. 2011 May;223(3):176-7. doi: 10.1055/s-0031-1273743. Epub 2011 Apr 1. Klin Padiatr. 2011. PMID: 21462099 No abstract available.
Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
von Bueren AO, von Hoff K, Pietsch T, Gerber NU, Warmuth-Metz M, Deinlein F, Zwiener I, Faldum A, Fleischhack G, Benesch M, Krauss J, Kuehl J, Kortmann RD, Rutkowski S. von Bueren AO, et al. Among authors: rutkowski s. Neuro Oncol. 2011 Jun;13(6):669-79. doi: 10.1093/neuonc/nor025. Neuro Oncol. 2011. PMID: 21636711 Free PMC article.
364 results